STEPHANIE PHILLIPS: Open Payments
NPI 1710370135 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 149 payments from 29 companies in 2025. Trend: 2023 $1,470 · 2024 $2,498 · 2025 $2,524
Food & beverage: $2,524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $374 |
| Novo Nordisk Inc | 18 | $363 |
| AstraZeneca Pharmaceuticals LP | 11 | $219 |
| GlaxoSmithKline, LLC. | 12 | $152 |
| PFIZER INC. | 10 | $148 |
| Lundbeck LLC | 8 | $133 |
| Lilly USA, LLC | 7 | $112 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Amgen Inc. | 6 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $90 |
Products named: REXULTI, VRAYLAR, Ozempic, FARXIGA, NURTEC ODT, TRELEGY ELLIPTA, MOUNJARO, UBRELVY.
Industry payments across NJ — which companies pay providers there.
